26 Citations
LSD use in the United States: Trends, correlates, and a typology of us.
- Medicine, PsychologyDrug and alcohol dependence
- 2021
Driving while under the influence of hallucinogens: Prevalence, correlates, and risk profiles.
- Medicine, PsychologyDrug and alcohol dependence
- 2021
Past-Year Ketamine Use: Evidence from a United States Population, 2015-2019.
- Psychology, MedicineJournal of psychoactive drugs
- 2022
Significant risk factors included past-year drug use and sexual minority status, with sexual minority males reporting more than use of one substance at highest risk for ketamine use.
Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019
- MedicineFrontiers in Epidemiology
- 2022
Findings should inform public health initiatives regarding potential benefits and risks of hallucinogen use among racial/ethnic groups and women.
An age-period-cohort analysis of trends in psychedelic and ecstasy use in the Australian population.
- Medicine, PsychologyAddictive behaviors
- 2021
Toward a typology of hallucinogen users in the United States.
- Medicine, PsychologyDrug and alcohol dependence
- 2021
Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment
- Psychology, Medicine
- 2021
Both psilocybin and MDMA have been granted ‘breakthrough therapy’ designation by the US Food and Drug Administration, and pending positive outcomes of ongoing and upcoming clinical trials, could emerge as a novel treatment paradigm with considerable ramifications for mental healthcare.
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
- Psychology, MedicineIrish Journal of Medical Science (1971 -)
- 2021
Younger people, those with previous recreational psychedelic experience, and those with non-religious beliefs were more likely to have favourable attitudes towards psilocybin therapy.
Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis
- BiologyCurrent Addiction Reports
- 2021
Given the substantial proportion of novel SPs in DC samples and the associated risks, DC can be a valuable harm reduction and monitoring tool for SPs if analysis techniques with high sensitivity are employed.
Psychedelic science in post-COVID-19 psychiatry
- Psychology, MedicineIrish Journal of Psychological Medicine
- 2020
Preliminary evidence from the rapidly progressing field of psychedelic science shows psilocybin therapy offers a promising transdiagnostic treatment strategy for a range of disorders with restricted and maladaptive habitual patterns of cognition and behaviour, notably depression, addiction and obsessive compulsive disorder.
References
SHOWING 1-10 OF 25 REFERENCES
Prevalence and risk factors for LSD use among young women.
- Psychology, MedicineJournal of pediatric and adolescent gynecology
- 2003
Let It Snow: Psychosocial Factors and Previous Substance Abuse Associated With Cocaine Use Among Bisexual Adults
- PsychologyJournal of Bisexuality
- 2019
Recommendations (e.g., focus groups, behavioral maintenance programs) for health professionals aimed at reducing substance abuse rates among sexual minority individuals are highlighted.
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
- Psychology, MedicineJournal of psychopharmacology
- 2015
It is indicated thatclassic psychedelics may hold promise in the prevention of suicide, supporting the view that classic psychedelics’ most highly restricted legal status should be reconsidered to facilitate scientific study, and suggesting that more extensive clinical research with classic psychedelic is warranted.
Past 15-year trends in lifetime cocaine use among US high school students.
- MedicineDrug and alcohol dependence
- 2018
Illicit drug use among New Zealand gay and bisexual men: Prevalence and association with sexual health behaviours
- Medicine, PsychologyDrug and alcohol review
- 2018
Polydrug and methamphetamine users had especially high sexual health needs, but risks remained elevated among GBM consuming other drugs, and drug harm reduction programs and HIV prevention should target GBM with problematic drug use.
Vital Signs: Demographic and Substance Use Trends Among Heroin Users — United States, 2002–2013
- MedicineMMWR. Morbidity and mortality weekly report
- 2015
Rates of heroin abuse or dependence were strongly positively correlated with rates of heroin-related overdose deaths over time and were highest among those with past-year cocaine or opioid pain reliever Abuse or dependence.
Over 30 million psychedelic users in the United States
- Psychology, MedicineF1000Research
- 2013
There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females).
“Go ask Alice, when she’s 10-feet tall”: Psychosocial correlates to lifetime LSD use among a national sample of US adults
- Psychology, MedicineJournal of Psychedelic Studies
- 2019
Analysis of psychosocial factors related to LSD use among a national sample of adults suggests that psychodynamic processes, for example, possible activation of emotional conflicts – can take place spontaneously – during ayahuasca intake in this particular setting.
Risk and Protective Factors and Estimates of Substance Use Initiation: Results from the 2016 National Survey on Drug Use and Health
- Medicine, Psychology
- 2012
The number of people in 2016 who initiated marijuana use in the past year was higher than the numbers in 2002 through 2008, but the numbers of recent marijuana use initiates were similar in 2009 to 2016, and the number of cocaine initiates in 2016 was similar to the number in 2015.
Regulation of human research with LSD in the United States (1949-1987)
- Psychology, MedicinePsychopharmacology
- 2017
How the 1962 Amendments introduced numerous safety and efficacy requirements that must be in satisfied during clinical drug research are detailed—and how human studies conducted with LSD in the 1960s struggled with their fulfillment.